54 346 (Lithium 450 mg)

Pill imprint 54 346 has been identified as Lithium carbonate extended release 450 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 54 346

Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346  Front
Lithium carbonate extended release 450 mg 54 346  Back
Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release
Imprint:
54 346
Strength:
450 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-0020
Inactive Ingredients:
ferrosoferric oxide
magnesium stearate
povidone
sodium alginate
sodium starch glycolate type A potato

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)